HIV and AIDS: Vaccine

Lord Collins of Highbury Excerpts
Monday 1st December 2014

(9 years, 11 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Asked by
Lord Collins of Highbury Portrait Lord Collins of Highbury
- Hansard - -



To ask Her Majesty’s Government what assessment they have made of the progress in developing a vaccine in order effectively to address global HIV/AIDS.

Baroness Northover Portrait The Parliamentary Under-Secretary of State, Department for International Development (Baroness Northover) (LD)
- Hansard - - - Excerpts

My Lords, today is, of course, World AIDS Day, and we have committed nearly £1 billion to tackling HIV through our programmes. There has been some progress on HIV vaccine research recently but no major breakthrough, although there are a number of promising research avenues. Expert opinion varies and it is not possible to say when a viable vaccine will be developed.

Lord Collins of Highbury Portrait Lord Collins of Highbury (Lab)
- Hansard - -

I thank the Minister for that response. UNAIDS highlighted that only 24% of children living with HIV currently have access to HIV treatment. Given the clear need for more investment, will the Minister support the recommendation in the report launched today by the all-party group, Access Denied, to carry out an inquiry into alternative models of research and development investment, which separate the costs of R&D from the demands of profitability?

Baroness Northover Portrait Baroness Northover
- Hansard - - - Excerpts

I will be speaking at the launch of that report later this afternoon, and no doubt we will have further discussions about it. One of the striking things about this is that in terms of research and development funding for new product development in 2012—the most recent figures available—33.6% went to HIV/AIDS, 17.1% towards malaria and 15% towards TB, so it is not a neglected area. But research into the vaccine is proving exceptionally difficult and the trials have proved disappointing. It is therefore necessary to move back to basic research and drive it forward that way. Meanwhile, a lot of effort is going into research and development on treatments. As the noble Lord will know, over the past decade there have been great advances in treatment. One of the key things, as my noble friend Lord Howe just indicated, is making sure that people know their status and are treated.